[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://www.scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGF\u00df) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Mr. David L. Hallal", "age": 58, "title": "CEO & Chairman of the Board", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 175732, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 704681, "exercisedValue": 0, "unexercisedValue": 3032789}, {"maxAge": 1, "name": "Dr. Akshay K. Vaishnaw M.D., Ph.D.", "age": 61, "title": "President of R&D, Member of Scientific Advisory Board and Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 56140, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 755185, "exercisedValue": 0, "unexercisedValue": 673489}, {"maxAge": 1, "name": "Mr. Vikas  Sinha C.A., CPA, M.B.A.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Keith Woods", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Moore CPA", "age": 49, "title": "Interim Principal Financial & Accounting Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1751328000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 39.11, "open": 39.07, "dayLow": 38.41, "dayHigh": 39.45, "regularMarketPreviousClose": 39.11, "regularMarketOpen": 39.07, "regularMarketDayLow": 38.41, "regularMarketDayHigh": 39.45, "payoutRatio": 0.0, "beta": 0.339, "forwardPE": -18.116278, "volume": 820463, "regularMarketVolume": 820463, "averageVolume": 1280703, "averageVolume10days": 1428930, "averageDailyVolume10Day": 1428930, "bid": 38.86, "ask": 39.02, "bidSize": 3, "askSize": 3, "marketCap": 3698131200, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 46.98, "fiftyDayAverage": 34.4323, "twoHundredDayAverage": 34.98825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3396897536, "profitMargins": 0.0, "floatShares": 79269100, "sharesOutstanding": 94945600, "sharesShort": 14173937, "sharesShortPriorMonth": 14932097, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.14930001, "heldPercentInsiders": 0.04354, "heldPercentInstitutions": 1.18521, "shortRatio": 9.81, "shortPercentOfFloat": 0.264, "impliedSharesOutstanding": 94945600, "bookValue": 3.292, "priceToBook": 11.831714, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -264164000, "trailingEps": -2.55, "forwardEps": -2.15, "enterpriseToEbitda": -12.628, "52WeekChange": 3.2568307, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 38.95, "targetHighPrice": 57.0, "targetLowPrice": 46.0, "targetMeanPrice": 51.0, "targetMedianPrice": 50.0, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 364375008, "totalCashPerShare": 3.838, "ebitda": -268992992, "totalDebt": 63143000, "quickRatio": 9.749, "currentRatio": 10.253, "debtToEquity": 20.217, "returnOnAssets": -0.50146, "returnOnEquity": -1.0671, "grossProfits": -190134000, "freeCashflow": -134323008, "operatingCashflow": -229839008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1753474800, "regularMarketTime": 1753473600, "regularMarketChangePercent": -0.409102, "regularMarketPrice": 38.95, "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_548810128", "market": "us_market", "postMarketChangePercent": 0.0, "postMarketPrice": 38.95, "postMarketChange": 0.0, "regularMarketChange": -0.16, "regularMarketDayRange": "38.41 - 39.45", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1280703, "fiftyTwoWeekLowChange": 32.190002, "fiftyTwoWeekLowChangePercent": 4.7618346, "fiftyTwoWeekRange": "6.76 - 46.98", "fiftyTwoWeekHighChange": -8.029999, "fiftyTwoWeekHighChangePercent": -0.17092377, "fiftyTwoWeekChangePercent": 325.68307, "earningsTimestamp": 1754483400, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754483400, "earningsCallTimestampStart": 1754481600, "earningsCallTimestampEnd": 1754481600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.55, "epsForward": -2.15, "epsCurrentYear": -2.722, "priceEpsCurrentYear": -14.309332, "fiftyDayAverageChange": 4.5177, "fiftyDayAverageChangePercent": 0.13120529, "twoHundredDayAverageChange": 3.96175, "twoHundredDayAverageChangePercent": 0.11323087, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "cryptoTradeable": false, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]